“The rating action reflects the significant deterioration in FRHG’s financial profile over the last two full fiscal years, with operating losses persisting through the first three months of fiscal 2017, driven in part by increased costs required to resolve regulatory compliance issues faced by the organization as well as by increased capital spending related to the construction of a new tower on FRHG’s main campus,” said S&P analyst Allison Bretz.
The outlook is stable.
More articles on healthcare finance:
HHS: Court order on Medicare appeals backlog would require improperly paying claims
Texas implements $350M in Medicaid cuts
CMS halts Medicare Part B drug payment demo
